Stay updated on Mepolizumab in Urban Children Asthma Trial
Sign up to get notified when there's something new on the Mepolizumab in Urban Children Asthma Trial page.

Latest updates to the Mepolizumab in Urban Children Asthma Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record for the completed MUPPITS-2 trial of mepolizumab for asthma exacerbations in urban children is displayed, including its protocol, participant criteria, outcome measures, publications, and data-sharing information.SummaryDifference73%

- Check19 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide notice announces NIH's transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page currently displays a 403 Forbidden error, with a header and site footer visible, replacing the previous detailed study content and related documentation. This indicates the record is temporarily inaccessible to users.SummaryDifference21%

Stay in the know with updates to Mepolizumab in Urban Children Asthma Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Urban Children Asthma Trial page.